Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)

angiogenesis Inhibitors, antineoplastic agents, bevacizumab, bias, brachytherapy, combined modality therapy, confidence intervals, gastric fistula, gastrointestinal hemorrhage, hypertension, indazoles, intestinal fistula, intestinal perforation, lapatinib, neoplasm recurrence local, progression-free survival, pyridines, pyrimidines, quality of life, quinazolines, randomized controlled trials as topic, sulfonamides, thromboembolism, uterine cervical neoplasms, vascular endothelial growth factor A